Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window

Intimation for closure of Trading Window
27-12-2023
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of duplicate share certificate, as per letter attached.
26-12-2023

Sun Pharma extends gains on $30-mn deal to buy Lyndra Therapeutics stake

The acquisition is expected to be completed by the end of December 2023, subject to certain conditions.
19-12-2023
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Acquisition

Intimation of agreement to acquire stake in Lyndra Therapeutics, Inc.
18-12-2023

Sun Pharma, Lupin recall drugs in US over manufacturing issues: USFDA

Lupin is also recalling an unspecified number of penicillamine tablets in the US due to failed dissolution specifications..Sun Pharma is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US due to failed impurities/degradation specifications.
17-12-2023
Bigul

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 15, 2023 for Raksha Sudhir Valia
16-12-2023

Sun Pharma's specialty product Ilumetri included in China's national reimbursement drug list

Ilumetri is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
13-12-2023
Next Page
Close

Let's Open Free Demat Account